VCT220
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
Vincentage Pharma Co · Phase 1 · Completed · Enrollment 24
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Participant Group | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.